Ambrx Biopharma Cayman, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
La Jolla, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Ambrx Biopharma Cayman, Inc. has filed 164 SEC EDGAR filings since 03 Feb 2021

SEC filing history

Showing 1-20 of 20 matching filings.

Per page
25
Current page
1
6-K File 001-40505

6-K

Filing date
16 Dec 2022
Reporting date
16 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
13 Dec 2022
Reporting date
13 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
01 Nov 2022
Reporting date
01 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

FORM 6-K

Filing date
18 Oct 2022
Reporting date
18 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
29 Aug 2022
Reporting date
29 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

FORM 6-K

Filing date
16 Aug 2022
Reporting date
16 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
05 Jul 2022
Reporting date
05 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
06 Jun 2022
Reporting date
06 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
17 May 2022
Reporting date
17 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
26 Apr 2022
Reporting date
26 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
07 Feb 2022
Reporting date
07 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
04 Jan 2022
Reporting date
04 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
09 Dec 2021
Reporting date
09 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
22 Nov 2021
Reporting date
22 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
08 Nov 2021
Reporting date
08 Nov 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

FORM 6-K

Filing date
28 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
28 Oct 2021
Reporting date
28 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
04 Oct 2021
Reporting date
04 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-40505

6-K

Filing date
02 Jul 2021
Reporting date
30 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .